No sooner than you thought all the talk of new COVID variants was over, there's news of yet another one: AY.4.2. But what is it, where did it come from, and should we be concerned?
Oct 28, 2021
0
18
The potential of scorpion venoms to combat the threat of new variants of coronavirus is being explored by scientists from the University of Aberdeen and the University of Suez Canal, Egypt.
Oct 25, 2021
0
12
The Centers for Disease Control and Prevention's (CDC) Genetic Testing Reference Material Program (GeT-RM) has partnered with the Clinical Genome Resource (ClinGen) to develop a publicly available list of 546 expert curated ...
Oct 12, 2021
0
0
A team from the Universitat Politècnica de València has just published a study analyzing the potential of plant extracts and/or natural compounds to inhibit the protease activity of the SARS-CoV-2 coronavirus.
Oct 7, 2021
0
15
US pharmaceutical company Merck said Friday it will seek authorization of its oral drug molnupiravir for COVID-19 after it was shown to reduce the chance newly infected patients were hospitalized by 50 percent.
Oct 1, 2021
0
37
People with an inherited condition known as neurofibromatosis type 1, or NF1, often develop non-cancerous, or benign, tumors that grow along nerves. These tumors can sometimes turn into aggressive cancers, but there hasn't ...
Aug 31, 2021
0
44
Cells translate their genetic material at rapid rates with exquisite precision to reproduce, repair damage or even combat disease. But the process can deregulate and give rise to disease. Byproducts of errant processes can ...
Aug 17, 2021
0
139
The United States recently secured 1.7 million doses of a compound that could help to treat COVID-19 patients. In preliminary studies, Molnupiravir reduced the transmission of the SARS-CoV-2 coronavirus. Researchers at the ...
Aug 16, 2021
0
1070
Researchers at the University of Bonn (Germany) have identified a previously unknown genetic program in the fruit fly. The genetic material involved controls the development of the neurons while also protecting them from ...
Aug 13, 2021
0
6
Researchers at Vanderbilt University Medical Center have found that people recovering from COVID-19 and those vaccinated against the causative virus, SARS-CoV-2, produce identical clones, or groups, of antibody-producing ...
Aug 13, 2021
0
461
